Skip to main content

Parisotto Shannon M's Form 4 filing

Charles River Laboratories International, Inc.CRL · filed Oct 7, 2026

Accession no.
0001952784-26-000003
Filed
Oct 7, 2026, 8:32 PM ET
Trade date
Oct 5, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $302.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Parisotto Shannon MCIK 0001952784Officer (CEVP, Disc & Safety Assessment)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 5, 2026Common StockMOption exerciseAcquired+981$208.44+$204,479.645,788Direct
Oct 5, 2026Common StockSSaleDisposed−981$308.44−$302,579.644,807Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 5, 2026Common StockMOption exerciseDisposed−981$0.00$02,944Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)